Cipla gets DCGI nod to sell Covid-19 drug Favipiravir under brand ‘Ciplenza’, to be launched in first week of August
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI)...
Health
Why chloroquine should not be used for Covid-19 treatment
London: The antimalarial drug chloroquine widely rumoured to help prevent Covid-19 is not able to prevent infection of human lung cells...
Australia’s Monash University develops 20-minute COVID-19 blood test
Melbourne: A blood test developed by Australia's Monash University could detect positive COVID-19 cases in about 20 minutes. Based on commonly...
‘COVID-19 vaccine to reach usable stage after 2020’
New Delhi: While India is set to begin the trials of its indigenous coronavirus vaccine from this week, a top official...
Turmeric compound could kill certain coronaviruses
Beijing: Aficionados of Indian food already know about the medicinal properties of turmeric. Now researchers have found that a natural compound...
Results show Moderna COVID-19 vaccine safe; phase 3 trials to start this month
New York: US-based pharmaceutical major Moderna's experimental vaccine, mRNA-1273, designed to protect against Covid-19 virus, was generally well tolerated and...
Surge in HIV, TB, malaria deaths due to Covid-19: Lancet
London: Some low- and middle-income countries (LMICs) could experience a surge in HIV, tuberculosis (TB), and malaria deaths over the...
Glenmark Pharmaceuticals cuts Fabiflu price by 27%
New Delhi: Glenmark Pharmaceuticals has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely...
It takes 18 months to develop good vaccine: Ex-ICMR chief
New Delhi: A good vaccine usually takes at least 18 months, before it could be rolled out for production after...
Scientists find new way to better diagnose malaria infection in India
Tokyo: Researchers have developed a new approach to study liver cell infection by a malaria parasite which could lead to...
